Agencies, 19 September: Aha hapta Pune te COVID-19 dawai Oxford University para develop kora aro Serum Institute of India (SII) para manufacture kora laga phase-III human clinical trial suru hobo. Etu khobor toh Saturday te Dean of state-run Sassoon General Hospital Dr Muralidhar Tambe para janaideya laga ase.
Tai para ‘Covishield’ vaccine laga phase-III trial toh Sassoon hospital te aha hapta para suru hobo koise. Etu trial toh Monday para suru hobo nesana ase koise. Etu trail nemide konbah volunteers be agae ahishe koise. 150 to 200 volunteers ke toh vaccine candidate dose nemide administered koribo ase koise.
Saturday para trial nemide hospital para volunteers ke enroll kora suru korise koise. Tai para be vaccination nemide kon volunteer koribole echa ase hospital te contact koribo lakibo koise. Phase-II pithor te, trial toh Bharti Vidyapeeth Medical College aro KEM Hospital te be lowa thakise.
SII para University of Oxford para bona COVID-19 vaccine candidate te manufacturing nemide British-Swedish pharma company AstraZeneca logode partner korise.
Etu moina agae hapta te, SII para desh te v accine candidate laga clinical trials toh rokhaideya thakise. Kelay koile Drugs Controller General of India (DCGI) para September 11 direk tak SII ke vaccine laga phase-II aro III cricinal trial nemide aro notun recruitment toh agae order nadiya tak nakoribole adesh deya nemide. DCGI para etu order deya toh AstraZeneca para tusara desh te trials rokhaideya nemide ase kelay koile study te hisha lowa manu ke kobo napara bemari howa nemide.
Add Comment